The global market for Coronavirus Spike Protein was valued at US$ 1452 million in the year 2024 and is projected to reach a revised size of US$ 2347 million by 2031, growing at a CAGR of 7.6% during the forecast period.

Coronavirus Spike Protein Market

Coronavirus Spike Protein (S Protein) is an important structural protein on the surface of coronaviruses that is responsible for virus binding to and invasion of host cells. The protein initiates the membrane fusion process by binding to the ACE2 receptor on the surface of the host cell, allowing the virus to enter the cell and begin replication. Due to the critical role of the echinocandin protein in the process of viral infection, it has become an important target for vaccines and antibody therapy.

North American market for Coronavirus Spike Protein is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Coronavirus Spike Protein is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Coronavirus Spike Protein include Abcam, Sanofi, The Native Antigen Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Agrisera, Merck KGaA (Sigma-Aldrich), Seebio, Elabscience, Novus Biologicals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coronavirus Spike Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronavirus Spike Protein.

The Coronavirus Spike Protein market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Coronavirus Spike Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Coronavirus Spike Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Coronavirus Spike Protein Market Report

Report Metric	Details
Report Name	Coronavirus Spike Protein Market
Accounted market size in year	US$ 1452 million
Forecasted market size in 2031	US$ 2347 million
CAGR	7.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	90%≤Purity≤95% Purity＞95% Other
Segment by Application	RDT & ELISA Vaccine Development Antiviral Drugs Research Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abcam, Sanofi, The Native Antigen Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Agrisera, Merck KGaA (Sigma-Aldrich), Seebio, Elabscience, Novus Biologicals, Sinobiological, Eagle Biosciences, BiosPacific
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Coronavirus Spike Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Coronavirus Spike Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Coronavirus Spike Protein Market growing?

Ans: The Coronavirus Spike Protein Market witnessing a CAGR of 7.6% during the forecast period 2025-2031.

What is the Coronavirus Spike Protein Market size in 2031?

Ans: The Coronavirus Spike Protein Market size in 2031 will be US$ 2347 million.

Who are the main players in the Coronavirus Spike Protein Market report?

Ans: The main players in the Coronavirus Spike Protein Market are Abcam, Sanofi, The Native Antigen Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Agrisera, Merck KGaA (Sigma-Aldrich), Seebio, Elabscience, Novus Biologicals, Sinobiological, Eagle Biosciences, BiosPacific

What are the Application segmentation covered in the Coronavirus Spike Protein Market report?

Ans: The Applications covered in the Coronavirus Spike Protein Market report are RDT & ELISA, Vaccine Development, Antiviral Drugs, Research, Other

What are the Type segmentation covered in the Coronavirus Spike Protein Market report?

Ans: The Types covered in the Coronavirus Spike Protein Market report are 90%≤Purity≤95%, Purity＞95%, Other

1 Coronavirus Spike Protein Market Overview

1.1 Product Definition

1.2 Coronavirus Spike Protein by Type

1.2.1 Global Coronavirus Spike Protein Market Value Comparison by Type (2024 VS 2031)

1.2.2 90%≤Purity≤95%

1.2.3 Purity＞95%

1.2.4 Other

1.3 Coronavirus Spike Protein by Application

1.3.1 Global Coronavirus Spike Protein Market Value by Application (2024 VS 2031)

1.3.2 RDT & ELISA

1.3.3 Vaccine Development

1.3.4 Antiviral Drugs

1.3.5 Research

1.3.6 Other

1.4 Global Coronavirus Spike Protein Market Size Estimates and Forecasts

1.4.1 Global Coronavirus Spike Protein Revenue 2020-2031

1.4.2 Global Coronavirus Spike Protein Sales 2020-2031

1.4.3 Global Coronavirus Spike Protein Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Coronavirus Spike Protein Market Competition by Manufacturers

2.1 Global Coronavirus Spike Protein Sales Market Share by Manufacturers (2020-2025)

2.2 Global Coronavirus Spike Protein Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Coronavirus Spike Protein Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Coronavirus Spike Protein, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Coronavirus Spike Protein, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Coronavirus Spike Protein, Product Type & Application

2.7 Global Key Manufacturers of Coronavirus Spike Protein, Date of Enter into This Industry

2.8 Global Coronavirus Spike Protein Market Competitive Situation and Trends

2.8.1 Global Coronavirus Spike Protein Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Coronavirus Spike Protein Players Market Share by Revenue

2.8.3 Global Coronavirus Spike Protein Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Coronavirus Spike Protein Market Scenario by Region

3.1 Global Coronavirus Spike Protein Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Coronavirus Spike Protein Sales by Region: 2020-2031

3.2.1 Global Coronavirus Spike Protein Sales by Region: 2020-2025

3.2.2 Global Coronavirus Spike Protein Sales by Region: 2026-2031

3.3 Global Coronavirus Spike Protein Revenue by Region: 2020-2031

3.3.1 Global Coronavirus Spike Protein Revenue by Region: 2020-2025

3.3.2 Global Coronavirus Spike Protein Revenue by Region: 2026-2031

3.4 North America Coronavirus Spike Protein Market Facts & Figures by Country

3.4.1 North America Coronavirus Spike Protein Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Coronavirus Spike Protein Sales by Country (2020-2031)

3.4.3 North America Coronavirus Spike Protein Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Coronavirus Spike Protein Market Facts & Figures by Country

3.5.1 Europe Coronavirus Spike Protein Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Coronavirus Spike Protein Sales by Country (2020-2031)

3.5.3 Europe Coronavirus Spike Protein Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Coronavirus Spike Protein Market Facts & Figures by Region

3.6.1 Asia Pacific Coronavirus Spike Protein Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Coronavirus Spike Protein Sales by Region (2020-2031)

3.6.3 Asia Pacific Coronavirus Spike Protein Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Coronavirus Spike Protein Market Facts & Figures by Country

3.7.1 Latin America Coronavirus Spike Protein Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Coronavirus Spike Protein Sales by Country (2020-2031)

3.7.3 Latin America Coronavirus Spike Protein Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Coronavirus Spike Protein Market Facts & Figures by Country

3.8.1 Middle East and Africa Coronavirus Spike Protein Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Coronavirus Spike Protein Sales by Country (2020-2031)

3.8.3 Middle East and Africa Coronavirus Spike Protein Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Coronavirus Spike Protein Sales by Type (2020-2031)

4.1.1 Global Coronavirus Spike Protein Sales by Type (2020-2025)

4.1.2 Global Coronavirus Spike Protein Sales by Type (2026-2031)

4.1.3 Global Coronavirus Spike Protein Sales Market Share by Type (2020-2031)

4.2 Global Coronavirus Spike Protein Revenue by Type (2020-2031)

4.2.1 Global Coronavirus Spike Protein Revenue by Type (2020-2025)

4.2.2 Global Coronavirus Spike Protein Revenue by Type (2026-2031)

4.2.3 Global Coronavirus Spike Protein Revenue Market Share by Type (2020-2031)

4.3 Global Coronavirus Spike Protein Price by Type (2020-2031)

5 Segment by Application

5.1 Global Coronavirus Spike Protein Sales by Application (2020-2031)

5.1.1 Global Coronavirus Spike Protein Sales by Application (2020-2025)

5.1.2 Global Coronavirus Spike Protein Sales by Application (2026-2031)

5.1.3 Global Coronavirus Spike Protein Sales Market Share by Application (2020-2031)

5.2 Global Coronavirus Spike Protein Revenue by Application (2020-2031)

5.2.1 Global Coronavirus Spike Protein Revenue by Application (2020-2025)

5.2.2 Global Coronavirus Spike Protein Revenue by Application (2026-2031)

5.2.3 Global Coronavirus Spike Protein Revenue Market Share by Application (2020-2031)

5.3 Global Coronavirus Spike Protein Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Abcam

6.1.1 Abcam Company Information

6.1.2 Abcam Description and Business Overview

6.1.3 Abcam Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Abcam Coronavirus Spike Protein Product Portfolio

6.1.5 Abcam Recent Developments/Updates

6.2 Sanofi

6.2.1 Sanofi Company Information

6.2.2 Sanofi Description and Business Overview

6.2.3 Sanofi Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sanofi Coronavirus Spike Protein Product Portfolio

6.2.5 Sanofi Recent Developments/Updates

6.3 The Native Antigen Company

6.3.1 The Native Antigen Company Company Information

6.3.2 The Native Antigen Company Description and Business Overview

6.3.3 The Native Antigen Company Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.3.4 The Native Antigen Company Coronavirus Spike Protein Product Portfolio

6.3.5 The Native Antigen Company Recent Developments/Updates

6.4 Bio-Rad Laboratories

6.4.1 Bio-Rad Laboratories Company Information

6.4.2 Bio-Rad Laboratories Description and Business Overview

6.4.3 Bio-Rad Laboratories Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Bio-Rad Laboratories Coronavirus Spike Protein Product Portfolio

6.4.5 Bio-Rad Laboratories Recent Developments/Updates

6.5 Thermo Fisher Scientific

6.5.1 Thermo Fisher Scientific Company Information

6.5.2 Thermo Fisher Scientific Description and Business Overview

6.5.3 Thermo Fisher Scientific Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Thermo Fisher Scientific Coronavirus Spike Protein Product Portfolio

6.5.5 Thermo Fisher Scientific Recent Developments/Updates

6.6 Agrisera

6.6.1 Agrisera Company Information

6.6.2 Agrisera Description and Business Overview

6.6.3 Agrisera Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Agrisera Coronavirus Spike Protein Product Portfolio

6.6.5 Agrisera Recent Developments/Updates

6.7 Merck KGaA (Sigma-Aldrich)

6.7.1 Merck KGaA (Sigma-Aldrich) Company Information

6.7.2 Merck KGaA (Sigma-Aldrich) Description and Business Overview

6.7.3 Merck KGaA (Sigma-Aldrich) Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Merck KGaA (Sigma-Aldrich) Coronavirus Spike Protein Product Portfolio

6.7.5 Merck KGaA (Sigma-Aldrich) Recent Developments/Updates

6.8 Seebio

6.8.1 Seebio Company Information

6.8.2 Seebio Description and Business Overview

6.8.3 Seebio Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Seebio Coronavirus Spike Protein Product Portfolio

6.8.5 Seebio Recent Developments/Updates

6.9 Elabscience

6.9.1 Elabscience Company Information

6.9.2 Elabscience Description and Business Overview

6.9.3 Elabscience Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Elabscience Coronavirus Spike Protein Product Portfolio

6.9.5 Elabscience Recent Developments/Updates

6.10 Novus Biologicals

6.10.1 Novus Biologicals Company Information

6.10.2 Novus Biologicals Description and Business Overview

6.10.3 Novus Biologicals Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Novus Biologicals Coronavirus Spike Protein Product Portfolio

6.10.5 Novus Biologicals Recent Developments/Updates

6.11 Sinobiological

6.11.1 Sinobiological Company Information

6.11.2 Sinobiological Description and Business Overview

6.11.3 Sinobiological Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Sinobiological Coronavirus Spike Protein Product Portfolio

6.11.5 Sinobiological Recent Developments/Updates

6.12 Eagle Biosciences

6.12.1 Eagle Biosciences Company Information

6.12.2 Eagle Biosciences Description and Business Overview

6.12.3 Eagle Biosciences Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Eagle Biosciences Coronavirus Spike Protein Product Portfolio

6.12.5 Eagle Biosciences Recent Developments/Updates

6.13 BiosPacific

6.13.1 BiosPacific Company Information

6.13.2 BiosPacific Description and Business Overview

6.13.3 BiosPacific Coronavirus Spike Protein Sales, Revenue and Gross Margin (2020-2025)

6.13.4 BiosPacific Coronavirus Spike Protein Product Portfolio

6.13.5 BiosPacific Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Coronavirus Spike Protein Industry Chain Analysis

7.2 Coronavirus Spike Protein Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Coronavirus Spike Protein Production Mode & Process Analysis

7.4 Coronavirus Spike Protein Sales and Marketing

7.4.1 Coronavirus Spike Protein Sales Channels

7.4.2 Coronavirus Spike Protein Distributors

7.5 Coronavirus Spike Protein Customer Analysis

8 Coronavirus Spike Protein Market Dynamics

8.1 Coronavirus Spike Protein Industry Trends

8.2 Coronavirus Spike Protein Market Drivers

8.3 Coronavirus Spike Protein Market Challenges

8.4 Coronavirus Spike Protein Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Abcam

Sanofi

The Native Antigen Company

Bio Rad Laboratories

Thermo Fisher Scientific

Agrisera

Merck KGaA(Sigma-Aldrich)

List of Tables

Table 1. Global Coronavirus Spike Protein Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Coronavirus Spike Protein Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Coronavirus Spike Protein Market Competitive Situation by Manufacturers in 2024

Table 4. Global Coronavirus Spike Protein Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Coronavirus Spike Protein Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Coronavirus Spike Protein Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Coronavirus Spike Protein Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Coronavirus Spike Protein Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Coronavirus Spike Protein, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Coronavirus Spike Protein, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Coronavirus Spike Protein, Product Type & Application

Table 12. Global Key Manufacturers of Coronavirus Spike Protein, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Coronavirus Spike Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Spike Protein as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Coronavirus Spike Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Coronavirus Spike Protein Sales by Region (2020-2025) & (K Units)

Table 18. Global Coronavirus Spike Protein Sales Market Share by Region (2020-2025)

Table 19. Global Coronavirus Spike Protein Sales by Region (2026-2031) & (K Units)

Table 20. Global Coronavirus Spike Protein Sales Market Share by Region (2026-2031)

Table 21. Global Coronavirus Spike Protein Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Coronavirus Spike Protein Revenue Market Share by Region (2020-2025)

Table 23. Global Coronavirus Spike Protein Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Coronavirus Spike Protein Revenue Market Share by Region (2026-2031)

Table 25. North America Coronavirus Spike Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Coronavirus Spike Protein Sales by Country (2020-2025) & (K Units)

Table 27. North America Coronavirus Spike Protein Sales by Country (2026-2031) & (K Units)

Table 28. North America Coronavirus Spike Protein Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Coronavirus Spike Protein Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Coronavirus Spike Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Coronavirus Spike Protein Sales by Country (2020-2025) & (K Units)

Table 32. Europe Coronavirus Spike Protein Sales by Country (2026-2031) & (K Units)

Table 33. Europe Coronavirus Spike Protein Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Coronavirus Spike Protein Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Coronavirus Spike Protein Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Coronavirus Spike Protein Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Coronavirus Spike Protein Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Coronavirus Spike Protein Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Coronavirus Spike Protein Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Coronavirus Spike Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Coronavirus Spike Protein Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Coronavirus Spike Protein Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Coronavirus Spike Protein Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Coronavirus Spike Protein Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Coronavirus Spike Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Coronavirus Spike Protein Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Coronavirus Spike Protein Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Coronavirus Spike Protein Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Coronavirus Spike Protein Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Coronavirus Spike Protein Sales (K Units) by Type (2020-2025)

Table 51. Global Coronavirus Spike Protein Sales (K Units) by Type (2026-2031)

Table 52. Global Coronavirus Spike Protein Sales Market Share by Type (2020-2025)

Table 53. Global Coronavirus Spike Protein Sales Market Share by Type (2026-2031)

Table 54. Global Coronavirus Spike Protein Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Coronavirus Spike Protein Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Coronavirus Spike Protein Revenue Market Share by Type (2020-2025)

Table 57. Global Coronavirus Spike Protein Revenue Market Share by Type (2026-2031)

Table 58. Global Coronavirus Spike Protein Price (US$/Unit) by Type (2020-2025)

Table 59. Global Coronavirus Spike Protein Price (US$/Unit) by Type (2026-2031)

Table 60. Global Coronavirus Spike Protein Sales (K Units) by Application (2020-2025)

Table 61. Global Coronavirus Spike Protein Sales (K Units) by Application (2026-2031)

Table 62. Global Coronavirus Spike Protein Sales Market Share by Application (2020-2025)

Table 63. Global Coronavirus Spike Protein Sales Market Share by Application (2026-2031)

Table 64. Global Coronavirus Spike Protein Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Coronavirus Spike Protein Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Coronavirus Spike Protein Revenue Market Share by Application (2020-2025)

Table 67. Global Coronavirus Spike Protein Revenue Market Share by Application (2026-2031)

Table 68. Global Coronavirus Spike Protein Price (US$/Unit) by Application (2020-2025)

Table 69. Global Coronavirus Spike Protein Price (US$/Unit) by Application (2026-2031)

Table 70. Abcam Company Information

Table 71. Abcam Description and Business Overview

Table 72. Abcam Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Abcam Coronavirus Spike Protein Product

Table 74. Abcam Recent Developments/Updates

Table 75. Sanofi Company Information

Table 76. Sanofi Description and Business Overview

Table 77. Sanofi Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Sanofi Coronavirus Spike Protein Product

Table 79. Sanofi Recent Developments/Updates

Table 80. The Native Antigen Company Company Information

Table 81. The Native Antigen Company Description and Business Overview

Table 82. The Native Antigen Company Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. The Native Antigen Company Coronavirus Spike Protein Product

Table 84. The Native Antigen Company Recent Developments/Updates

Table 85. Bio-Rad Laboratories Company Information

Table 86. Bio-Rad Laboratories Description and Business Overview

Table 87. Bio-Rad Laboratories Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Bio-Rad Laboratories Coronavirus Spike Protein Product

Table 89. Bio-Rad Laboratories Recent Developments/Updates

Table 90. Thermo Fisher Scientific Company Information

Table 91. Thermo Fisher Scientific Description and Business Overview

Table 92. Thermo Fisher Scientific Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Thermo Fisher Scientific Coronavirus Spike Protein Product

Table 94. Thermo Fisher Scientific Recent Developments/Updates

Table 95. Agrisera Company Information

Table 96. Agrisera Description and Business Overview

Table 97. Agrisera Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Agrisera Coronavirus Spike Protein Product

Table 99. Agrisera Recent Developments/Updates

Table 100. Merck KGaA (Sigma-Aldrich) Company Information

Table 101. Merck KGaA (Sigma-Aldrich) Description and Business Overview

Table 102. Merck KGaA (Sigma-Aldrich) Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Merck KGaA (Sigma-Aldrich) Coronavirus Spike Protein Product

Table 104. Merck KGaA (Sigma-Aldrich) Recent Developments/Updates

Table 105. Seebio Company Information

Table 106. Seebio Description and Business Overview

Table 107. Seebio Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Seebio Coronavirus Spike Protein Product

Table 109. Seebio Recent Developments/Updates

Table 110. Elabscience Company Information

Table 111. Elabscience Description and Business Overview

Table 112. Elabscience Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Elabscience Coronavirus Spike Protein Product

Table 114. Elabscience Recent Developments/Updates

Table 115. Novus Biologicals Company Information

Table 116. Novus Biologicals Description and Business Overview

Table 117. Novus Biologicals Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Novus Biologicals Coronavirus Spike Protein Product

Table 119. Novus Biologicals Recent Developments/Updates

Table 120. Sinobiological Company Information

Table 121. Sinobiological Description and Business Overview

Table 122. Sinobiological Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Sinobiological Coronavirus Spike Protein Product

Table 124. Sinobiological Recent Developments/Updates

Table 125. Eagle Biosciences Company Information

Table 126. Eagle Biosciences Description and Business Overview

Table 127. Eagle Biosciences Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Eagle Biosciences Coronavirus Spike Protein Product

Table 129. Eagle Biosciences Recent Developments/Updates

Table 130. BiosPacific Company Information

Table 131. BiosPacific Description and Business Overview

Table 132. BiosPacific Coronavirus Spike Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. BiosPacific Coronavirus Spike Protein Product

Table 134. BiosPacific Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Coronavirus Spike Protein Distributors List

Table 138. Coronavirus Spike Protein Customers List

Table 139. Coronavirus Spike Protein Market Trends

Table 140. Coronavirus Spike Protein Market Drivers

Table 141. Coronavirus Spike Protein Market Challenges

Table 142. Coronavirus Spike Protein Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Coronavirus Spike Protein

Figure 2. Global Coronavirus Spike Protein Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Coronavirus Spike Protein Market Share by Type: 2024 & 2031

Figure 4. 90%≤Purity≤95% Product Picture

Figure 5. Purity＞95% Product Picture

Figure 6. Other Product Picture

Figure 7. Global Coronavirus Spike Protein Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Coronavirus Spike Protein Market Share by Application: 2024 & 2031

Figure 9. RDT & ELISA

Figure 10. Vaccine Development

Figure 11. Antiviral Drugs

Figure 12. Research

Figure 13. Other

Figure 14. Global Coronavirus Spike Protein Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Coronavirus Spike Protein Market Size (2020-2031) & (US$ Million)

Figure 16. Global Coronavirus Spike Protein Sales (2020-2031) & (K Units)

Figure 17. Global Coronavirus Spike Protein Average Price (US$/Unit) & (2020-2031)

Figure 18. Coronavirus Spike Protein Report Years Considered

Figure 19. Coronavirus Spike Protein Sales Share by Manufacturers in 2024

Figure 20. Global Coronavirus Spike Protein Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Coronavirus Spike Protein Players: Market Share by Revenue in Coronavirus Spike Protein in 2024

Figure 22. Coronavirus Spike Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Coronavirus Spike Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Coronavirus Spike Protein Sales Market Share by Country (2020-2031)

Figure 25. North America Coronavirus Spike Protein Revenue Market Share by Country (2020-2031)

Figure 26. United States Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Coronavirus Spike Protein Sales Market Share by Country (2020-2031)

Figure 29. Europe Coronavirus Spike Protein Revenue Market Share by Country (2020-2031)

Figure 30. Germany Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Coronavirus Spike Protein Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Coronavirus Spike Protein Revenue Market Share by Region (2020-2031)

Figure 37. China Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. China Taiwan Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Coronavirus Spike Protein Sales Market Share by Country (2020-2031)

Figure 45. Latin America Coronavirus Spike Protein Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Colombia Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Coronavirus Spike Protein Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Coronavirus Spike Protein Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Coronavirus Spike Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Coronavirus Spike Protein by Type (2020-2031)

Figure 56. Global Revenue Market Share of Coronavirus Spike Protein by Type (2020-2031)

Figure 57. Global Coronavirus Spike Protein Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Coronavirus Spike Protein by Application (2020-2031)

Figure 59. Global Revenue Market Share of Coronavirus Spike Protein by Application (2020-2031)

Figure 60. Global Coronavirus Spike Protein Price (US$/Unit) by Application (2020-2031)

Figure 61. Coronavirus Spike Protein Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Plant-based Fat Powder Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37M19032

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Coronavirus Spike Protein Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14A19115

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Urinary Tract Supplements Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13R19093

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Trace Impurities Analyzer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29F11161

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions